Secular trends drive deals in the middle market
With M&A activity in the global healthcare sector at record levels in recent years, activity in the European healthcare middle-market segment has been no exception. Activity in the space is being driven by:
- More resilient, visible and defensible growth than other sectors
- Private equity continuing to favour healthcare as one of their key investment sectors
- Strategic buyers, as global consolidation has accelerated in response to post 2008 crisis trends
In this report and the video below, Baird discusses the market and M&A trends in the medical technology, life sciences, pharmaceutical, outsourcing, healthcare IT and healthcare services subsectors. Baird analysed over 200 middle-market M&A transactions in Europe. The average valuation multiple in Baird’s analysis was 11x EBITDA.
Learn more about Baird’s Healthcare Platform.